Add like
Add dislike
Add to saved papers

First hydrogen operation of NIO1: Characterization of the source plasma by means of an optical emission spectroscopy diagnostic.

NIO1 (Negative Ion Optimization 1) is a compact and flexible radio frequency H(-) ion source, developed by Consorzio RFX and INFN-LNL. The aim of the experimentation on NIO1 is the optimization of both the production of negative ions and their extraction and beam optics. In the initial phase of its commissioning, NIO1 was operated with nitrogen, but now the source is regularly operated also with hydrogen. To evaluate the source performances, an optical emission spectroscopy diagnostic was installed. The system includes a low resolution spectrometer in the spectral range of 300-850 nm and a high resolution (50 pm) one, to study, respectively, the atomic and the molecular emissions in the visible range. The spectroscopic data have been interpreted also by means of a collisional-radiative model developed at IPP Garching. Besides the diagnostic hardware and the data analysis methods, the paper presents the first plasma measurements across a transition to the full H mode, in a hydrogen discharge. The characteristic signatures of this transition in the plasma parameters are described, in particular, the sudden increase of the light emitted from the plasma above a certain power threshold.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app